Blood tests for blood vessel problems in type 2 diabetes
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study looks at whether certain blood tests (called NLR and PLR) can help predict blood vessel problems and blood sugar control in people with type 2 diabetes. The goal is to see if these simple tests could help guide better treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have been diagnosed with type 2 diabetes (not type 1).
- You need to have a recent HbA1c test result – this shows your average blood sugar over the last 2–3 months, and it can be below 7% or 7% or higher.
- You should not have certain conditions like low blood platelets, liver failure, blood cancers, or be taking blood thinners, antiplatelet drugs, or steroids.
- You should not have type 1 diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood cells and blood type in people with type 2 diabetes to see if they can predict complications. It may help doctors better understand and manage diabetes-related health issues.
This early study looks at how “autophagy” (your body’s cell recycling process) relates to small blood-vessel problems in people with type 2 diabetes. It may help researchers understand mechanisms and possible future treatments, mainly for people who meet specific health and medication criteria.
This study looks at how well controlling blood sugar affects heart function in people with type 2 diabetes who also have heart disease. It may help show if better blood sugar management can improve heart health.
This study looks at how platelets (the cells that help blood clot) may be affected in people with type 2 diabetes. It aims to understand if diabetes changes platelet function, which could help improve heart health in the future.
This study looks at how type 1 diabetes affects small blood vessels, especially in the eyes, kidneys, and feet. It tests a special camera and other devices to see how severe the damage is, which may help doctors find better ways to treat complications early.
This study measures immune cells from your blood to find markers (biomarkers) that may explain or predict diabetic cardiomyopathy, a type of heart condition linked to diabetes. You may benefit mainly by being closely monitored and contributing to research that could improve future diagnosis or risk tracking.
Hear when a new Vascular Complication, Diabetic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.